Pleural effusion and empyema are conditions characterized ... showing promise in breaking down loculated pleural collections and facilitating drainage[2]. However, further studies are needed ...

Background: Ascites and pleural effusion are well recognized complications of pancreatic diseases. Drug therapy of these is limited by high cost, prolonged hospitalization and failure rates ...

Additional pleural pathology was identified on ... pericardial fenestration is safe and effective for loculated pericardial effusions previously treated by percutaneous drainage manoeuvres and ...

Lung Therapeutics’ first therapeutic candidate LTI-01 recently completed a phase 1b clinical trial in Australia and New Zealand for the treatment of loculated pleural effusions, a life ...

Pleurisy, or pleural effusion, is a condition in which the pleura, two large, thin layers of tissue that separate your lungs from your chest wall becomes inflamed. Not all patients will need ...

Rein also provided an update on its pipeline, highlighting LTI-01, a Phase 2b-ready therapy for loculated pleural effusions, which holds Orphan Drug Designation for pleural empyema. Brian Windsor ...

As well as the IPF candidate, the merger gave Aileron a phase-2b-ready treatment for loculated pleural effusions and a cystic fibrosis program. Finding funding for the programs remains an issue.